Commentary: Tubercular posterior scleritis - Nuances in practice!

Murugan, S Bala

doi:10.4103/ijo.ijo_695_19

Cited by 1 publication

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a multicentric study by Lane et al ., presumed ocular tuberculosis accounted for 75% of infectious cases in India. [ 67 ] Tuberculous scleritis may be the result either of a direct MTB scleral invasion but more often is caused by an immune-mediated process[ 68 69 70 ] [Fig. 3a - c ].…”

Section: Types Of Infectious Scleritismentioning

confidence: 99%

“…The patient should be thoroughly investigated to look for systemic involvement (primary focus) with Mantoux test, sputum examination and high resolution scan chest CT. Anti-tubercular therapy includes ethambutol (400 mg orally twice a day), isoniazid (300 mg orally once a day), rifampin (600 mg orally once a day), and pyridoxine (50 mg orally once a day) for 6–12 months. [ 70 ] [ Fig. 3d ] shows clinical photograph of a patient with tubercular scleral abscess and lung cavitation [ Fig.…”

Section: Types Of Infectious Scleritismentioning

confidence: 99%

See 1 more Smart Citation

Scleritis: Differentiating infectious from non-infectious entities

Murthy

Sabhapandit

Balamurugan

et al. 2020

Indian J Ophthalmol

View full text Add to dashboard Cite

Scleritis is a rare painful ocular disorder, associated with severe ocular pain and tissue destruction. Although a majority of these cases are immune mediated and at least half of these are associated with systemic immune-mediated diseases, a smaller minority are due to infections of the sclera. The two conditions closely mimic each other, and a thorough knowledge of the subtle differences is necessary in order to reach a timely diagnosis. Diagnostic delay can lead to a poor outcome both due to the destruction caused by the uncontrolled infection and also due to propagation of the infection with the use of corticosteroids which may have been started for presumed immune mediated scleritis. In this review, we present the clinical features, etiological agents, and the differentiating features between immune and infectious scleritis. We also present diagnostic and management guidelines for managing scleral infection.

show abstract